Location · Ann Arbor, MI
Clinical trials in Ann Arbor, MI
251 recruiting studies have a site in Ann Arbor, and 72 of them accept healthy volunteers.
251 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 2/Phase 3
A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
Janssen Research & Development, LLC
- Location
- Ann Arbor, MI + 7 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 2
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
PPD Development, LP
- Location
- Ann Arbor, MI + 27 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
PPD Development, LP
- Location
- Ann Arbor, MI + 27 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
PPD Development, LP
- Location
- Ann Arbor, MI + 27 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
PPD Development, LP
- Location
- Ann Arbor, MI + 26 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
W.L.Gore & Associates
- Location
- Ann Arbor, MI + 30 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 2
Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
RAPT Therapeutics, Inc., a member of the GSK plc group of companies
- Location
- Ann Arbor, MI + 21 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingPhase 1
A Study of AZD0120 in Autoimmune Diseases
AstraZeneca
- Location
- Ann Arbor, MI + 1 other US site
- Eligibility basics
- Ages 18–75
- Recruiting
Early Feasibility Study (EFS) of the Nyra Cardiac Leaflet Enhancer (CARLEN) System
Nyra Medical, Inc.
- Location
- Ann Arbor, MI + 2 other US sites
- Eligibility basics
- Ages 21+
- Recruiting
The TRICURE EFS Study
TRiCares
- Location
- Ann Arbor, MI + 7 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
Arga Medtech SA
- Location
- Ann Arbor, MI + 17 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Pfizer
- Location
- Ann Arbor, MI + 30 other US sites
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingPhase 2/Phase 3
A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
Priovant Therapeutics, Inc.
- Location
- Ann Arbor, MI + 44 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
Sanofi
- Location
- Ann Arbor, MI + 11 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Global Trial in APG2575 for Patients With CLL/SLL
Ascentage Pharma Group Inc.
- Location
- Ann Arbor, MI + 10 other US sites
- Eligibility basics
- Ages 18–99
- RecruitingPhase 3
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney…
Alexion Pharmaceuticals, Inc.
- Location
- Ann Arbor, MI + 28 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.
Pfizer
- Location
- Ann Arbor, MI + 13 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
Nkarta, Inc.
- Location
- Ann Arbor, MI + 15 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Ardelyx
- Location
- Ann Arbor, MI + 108 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis
Rapamycin Holdings Inc.
- Location
- Ann Arbor, MI + 17 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature
BioMarin Pharmaceutical
- Location
- Ann Arbor, MI + 30 other US sites
- Eligibility basics
- Ages 3–11
- RecruitingPhase 3
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
Takeda
- Location
- Ann Arbor, MI + 32 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Travere Therapeutics, Inc.
- Location
- Ann Arbor, MI + 16 other US sites
- Eligibility basics
- Ages 1–17
- RecruitingPhase 4
Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy
ARS Pharmaceuticals, Inc.
- Location
- Ann Arbor, MI + 5 other US sites
- Eligibility basics
- Ages 4+